🇺🇸 Phathom Pharmaceuticals, Inc.
Forum topic · PHAT · Company page: financials, ownership and filings
Join the discussion on Phathom Pharmaceuticals, Inc.
Loading…
Results announced on 29 October 2026
Phathom Pharmaceuticals, Inc. announced results on 29 October 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $85 million (up 71% from a year earlier) and a net loss of $14 million.
Mutual funds: 136 funds hold $184 million
136 mutual funds in 1 country hold shares of Phathom Pharmaceuticals, Inc. worth $184 million, about 22.5% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 79 funds added shares and 34 sold; on balance they bought $12 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.